newsfilter
← Latest News
GlobeNewswire·

ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent

ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent Catalent acquired ERYTECH's U.S. cell therapy manufacturing facility for a total consideration of USD 44.5 million ERYTECH and Cat